Risk Factors for High-Risk Human Papillomavirus Infection and Cofactors for High-Grade Cervical Disease in Peru

被引:21
|
作者
Almonte, Maribel [1 ]
Ferreccio, Catterina [2 ]
Gonzales, Miguel [3 ,4 ]
Delgado, Jose Manuel [4 ,5 ]
Buckley, C. Hilary [6 ]
Luciani, Silvana [4 ]
Robles, Sylvia C. [4 ]
Winkler, Jennifer L. [7 ]
Tsu, Vivien D. [7 ]
Jeronimo, Jose [7 ]
Cuzick, Jack [1 ]
Sasieni, Peter [1 ]
机构
[1] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London EC1M 6BQ, England
[2] Pontificia Univ Catolica Chile, Santiago, Chile
[3] Direcc Reg Salud DIRES San Martin, Tarapoto, Peru
[4] Pan Amer Hlth Org, Washington, DC USA
[5] Univ Nacl San Martin, Tarapoto, Peru
[6] St Marys Hosp, Dept Pathol, Manchester M13 0JH, Lancs, England
[7] PATH, Seattle, WA USA
关键词
Human papillomavirus; Cervical cancer; Cervical screening; Risk factors; POOLED ANALYSIS; HPV INFECTION; WOMEN; CANCER; PREVALENCE; NEOPLASIA; EPIDEMIOLOGY; CYTOLOGY; AGE;
D O I
10.1097/IGC.0b013e3182288104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To evaluate the association between potential risk factors for high-risk human papillomavirus (HR-HPV) infection and cofactors for cervical intraepithelial lesions grade 2 or worse (CIN2+) in women attending cervical screening in Amazonian Peru. Materials and Methods: Participants completed a risk factor questionnaire before screening. High-risk human papillomavirus infection was determined by Hybrid Capture II. Logistic regression was used to evaluate associations between potential risk factors for HR-HPV infection and between cofactors and risk of CIN2+ among women with HR-HPV infection. Results: Screening and questionnaires were completed by 5435 women aged 25 to 49 years. The prevalence of HR-HPV was 12.6% (95% confidence interval [CI], 11.8%-13.6%) and decreased by age. Early age at first sexual intercourse and several lifetime sexual partners increased the risk of having HR-HPV (age-adjusted odds ratio [AOR] of age at first sexual intercourse <18 vs >= 20, 1.5; 95% CI, 1.2-2.0; AOR of >= 5 lifetime sexual partners vs 1, 2.1; 95% CI, 1.4-3.2). Among women with HR-HPV infection, those with no schooling (AOR relative to 1-5 years of schooling, 3.2; 95% CI, 1.3-8.3) and those with parity >= 3 (AOR relative to parity <3, 2.6; 95% CI, 1.4-4.9) were at increased risk of CIN2+. The effect of parity was stronger for cancer (AOR of parity >= 3 vs <3, 8.3; 95% CI, 1.0-65.6). Further analysis showed that the association between parity and CIN2+ was restricted to women younger than 40. Most women (83%) had previously been screened. Sixty-four percent of CIN2+ cases detected in this study occurred in women who reported having had a Papanicolaou test in the previous 3 years. Only 4 of 20 cancers were detected in women never screened before. Having had a previous abnormal Papanicolaou test increased the risk of CIN2+ (OR, 16.1; 95% CI, 6.2-41.9). Conclusion: Among women with HR-HPV, high parity (in young women), no schooling, lack of good-quality screening and of adequate follow-up care are the main risk factors for high-grade cervical disease in Peru.
引用
收藏
页码:1654 / 1663
页数:10
相关论文
共 50 条
  • [41] High-Risk Human Papillomavirus Detection in Urine Samples From a Referral Population With Cervical Biopsy-Proven High-Grade Lesions
    Lorenzi, Adriana T.
    Fregnani, Jose Humberto T.
    Dockter, Janel
    Fitzgerald, Kerry
    Strohecker, Elizabeth
    Eaton, Barbara
    Vibat, Cecile Rose T.
    Erlander, Mark G.
    Scapulatempo-Neto, Cristovam
    Smith, Jennifer S.
    Longatto-Filho, Adhemar
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2018, 22 (01) : 17 - 20
  • [42] Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease
    Radley, David
    Saah, Alfred
    Stanley, Margaret
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (03) : 768 - 772
  • [43] High-risk human papillomavirus infection and cervical cytopathology: relationship with cervical nitric oxide levels
    El-Wakil, Doaa Mahdy
    Shaker, Olfat G.
    Rashwan, Ahmed S. S. A.
    Elesawy, Yasmine Fathy
    Samir, Nermin
    VIROLOGY JOURNAL, 2024, 21 (01)
  • [44] Prevalence and Seroprevalence of High-Risk Human Papillomavirus Infection
    Kim, Min-A
    Oh, Jin-Kyoung
    Chay, Doo Byung
    Park, Dong Choon
    Kim, Seok Mo
    Kang, Eun-Suk
    Kim, Jae-Hoon
    Cho, Chi-Heum
    Shin, Hai-Rim
    Seo, Kyung
    OBSTETRICS AND GYNECOLOGY, 2010, 116 (04): : 932 - 940
  • [45] Is risk of high-grade cervical lesions similar for all oncogenic types of human papillomavirus (HPV)?
    Bejtja, G
    Balasubramanian, A
    Harris, TG
    Hawes, S
    Kiviat, NB
    Mao, C
    Feng, Q
    Koutsky, LA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (11) : S37 - S37
  • [46] Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer
    Carrillo-Garcia, Adela
    Ponce-de-Leon-Rosales, Sergio
    Cantu-de-Leon, David
    Fragoso-Ontiveros, Veronica
    Martinez-Ramirez, Imelda
    Orozco-Colin, Asuncion
    Mohar, Alejandro
    Lizano, Marcela
    GYNECOLOGIC ONCOLOGY, 2014, 134 (03) : 534 - 539
  • [47] High Rates of High-Grade Cervical Dysplasia in High-Risk Young Women With Low-Grade Cervical Cytology
    Daily, Laura R.
    Erickson, Britt K.
    Pasko, Daniel N.
    Straughn, J. Michael
    Huh, Warner K.
    Leath, Charles A., III
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2018, 22 (03) : 207 - 211
  • [48] Infection with high-risk Human Papillomavirus (HPV) and the risk of female infertility
    Nohr, B.
    Kjaer, S. Kruger
    Soylu, L.
    Jensen, A.
    HUMAN REPRODUCTION, 2017, 32 : 137 - 138
  • [49] Characteristics and Related Factors of High-Risk Human Papillomavirus Infection in Pregnant Women
    Chen, Yingying
    Dong, Jie
    Chu, Boliang
    Zhang, Xiaoxing
    Ru, Xiaofang
    Chen, Yun
    Chen, Yunyan
    Cheng, Xiaodong
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [50] HUMAN PAPILLOMAVIRUS INFECTION AFTER TREATMENT FOR HIGH-GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA
    Shikova, E.
    Ivanova, Z.
    Zvirbliene, A.
    Ganchev, G.
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2012, 26 : 85 - 88